Newly Approved Hematology and Oncology Agents: 2016 (Part 1)

November 5, 2016

Learning Objectives

  • Discuss the pharmacology and indications of medications approved in the year 2015-2016 for the management of patients with cancer or hematologic diseases
  • Describe recommended monitoring and management of toxicities of these agents
  • Describe the impact of these agents in advanced practice
Course summary
Available credit: 
  • 0.75 ACPE
  • 0.75 AMA PRA Category 1 Credit(s)™
  • 0.75 Attendance
  • 0.75 ANCC
Course opens: 
11/05/2016
Course expires: 
06/08/2017
Event starts: 
11/05/2016 - 11:15am
Event ends: 
11/05/2016 - 12:00pm
Cost:
$0.00
Parent activity set: 
Rating: 
5
Gaylord National Hotel
National Harbor, MD
United States

Available Credit

  • 0.75 ACPE
  • 0.75 AMA PRA Category 1 Credit(s)™
  • 0.75 Attendance
  • 0.75 ANCC

Price

Cost:
$0.00
Please login or register to take this course.